AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases
Benjamin P Brown; Jeffrey Skolnick
In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development.
Science and technology editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in computational systems biology at Georgia Institute of Technology, and Benjamin P. Brown, assistant professor of pharmacology at Vanderbilt University.
Skolnick has developed AI-based approaches to predict protein structure and function that may help with drug discovery and finding off-label uses...